4//SEC Filing
Sanders Reginald J. 4
Accession 0001562180-25-000272
CIK 0001314102other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:14 PM ET
Size
5.7 KB
Accession
0001562180-25-000272
Insider Transaction Report
Form 4
Sanders Reginald J.
Director
Transactions
- Award
Stock Options (Right to buy)
2025-01-08+80,000→ 80,000 totalExercise: $9.11Exp: 2035-01-08→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in three ratable annual installments beginning on January 8, 2026.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0002048275
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:14 PM ET
- Size
- 5.7 KB